Talarico Rosaria, Marinello Diana, Cannizzo Sara, Palla Ilaria, Ticciati Simone, Gaglioti Andrea, Rys Andrzej, Milli Carlo, Taruscio Domenica, Mosca Marta, Turchetti Giuseppe
Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Front Health Serv. 2022 Jul 13;2:935014. doi: 10.3389/frhs.2022.935014. eCollection 2022.
As a matter of fact, organisation always matters when discussing about healthcare, since it is fundamental in order to ensure the delivery of the most appropriate care to patients in the most appropriate way. Unfortunately, the pandemic brought by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) imposed a huge reorganisation of the healthcare systems, with several repercussions on the care of several chronic conditions, that were in many cases discontinued. This was the case of rare diseases (RDs), conditions that even under normal circumstances can experience diagnostic delays and difficulties in receiving appropriate care. The context of the European Reference Networks (ERNs) represents one of the most appropriate settings for the creation of organisational reference models for patient care pathways (PCP). As a matter of fact, the main mission of ERNs is to improve the care of patients with RDs in Europe through a patient-centred approach, thanks to real multistakeholder involvement. For this reason, in the last years, an extensive effort has been made towards the creation of a methodological approach aimed at providing organisational reference models for PCP in RDs across the different Member States. In fact, in order to develop the reference model, a structured methodology was created to enable the design of the PCP based on a deep sharing of expertise on high-quality care and characterised by a strong patient-centred approach: RarERN Path™. Among the different stakeholders that need to be involved in planning strategic actions to ensure care also during an emergency, patients' representatives, healthcare professionals, hospital managers, and experts in healthcare organisations play a crucial role.
事实上,在讨论医疗保健时,组织始终至关重要,因为它是确保以最恰当的方式为患者提供最合适护理的基础。不幸的是,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的疫情对医疗系统进行了大规模重组,对多种慢性病的护理产生了诸多影响,在许多情况下,这些护理都中断了。罕见病(RDs)就是如此,即使在正常情况下,这些疾病也可能出现诊断延迟以及获得适当护理方面的困难。欧洲参考网络(ERNs)的背景是创建患者护理路径(PCP)组织参考模型的最合适环境之一。事实上,ERNs的主要使命是通过以患者为中心的方法,借助真正的多利益相关方参与,改善欧洲罕见病患者的护理。因此,在过去几年里,人们为创建一种方法学付出了巨大努力,旨在为不同成员国的罕见病患者护理路径提供组织参考模型。实际上,为了开发参考模型,创建了一种结构化方法,以便基于对高质量护理专业知识的深入共享来设计患者护理路径,并以强烈的以患者为中心的方法为特征:RarERN Path™。在需要参与规划战略行动以确保即使在紧急情况下也能提供护理的不同利益相关方中,患者代表、医疗保健专业人员、医院管理人员以及医疗保健组织专家发挥着关键作用。